Evidence map›Paper›PMID 34485660›Full record

ArticleGynecologic oncology reports2021

Benjamin Margolis, Fanny Dao, Michael Licciardi, Selim Misirlioglu, Narciso Olvera, Sitharam Ramaswami, Douglas A Levine

Open access · goldAbstract read
In one paragraph

Article in Gynecologic oncology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Genomic instability andFrontiers in oncology · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Benjamin MargolisLaura and Isaac Perlmutter Comprehensive Cancer Center, NYU Langone Health, 550 1st Avenue, New York, NY 10016, USA.
Fanny DaoLaura and Isaac Perlmutter Comprehensive Cancer Center, NYU Langone Health, 550 1st Avenue, New York, NY 10016, USA.
Michael LicciardiLaura and Isaac Perlmutter Comprehensive Cancer Center, NYU Langone Health, 550 1st Avenue, New York, NY 10016, USA.
Selim MisirliogluLaura and Isaac Perlmutter Comprehensive Cancer Center, NYU Langone Health, 550 1st Avenue, New York, NY 10016, USA.
Narciso OlveraLaura and Isaac Perlmutter Comprehensive Cancer Center, NYU Langone Health, 550 1st Avenue, New York, NY 10016, USA.
Sitharam RamaswamiGenome Technology Center, NYU Langone Health, 550 First Avenue, New York, NY 10016, USA.
Douglas A LevineLaura and Isaac Perlmutter Comprehensive Cancer Center, NYU Langone Health, 550 1st Avenue, New York, NY 10016, USA.
NYU Langone Health · USNew York Genome Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe sought to characterize the variability of

methodsPatients with

resultsFour of 15 patients from an institutional database screened by ddPCR were found to have

conclusions

Indexed as

CCNE1Copy numberMetastasisOvarian cancer

Identifiers

PMID34485660
PMCPMC8391017
OpenAlexW3193582631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.